Is Alimera Sciences Inc (ALIM) Stock at the Top of the Drug Manufacturers

A rating of 76 puts Alimera Sciences Inc (ALIM) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Alimera Sciences Inc's score of 76 means it scores higher than 76% of stocks in the industry. Alimera Sciences Inc also received an overall rating of 43, putting it above 43% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 143 out of the 148 industries.

ALIM has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on ALIM!

See Full ALIM Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 43 would rank higher than 43 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Alimera Sciences Inc Stock Today?

Alimera Sciences Inc (ALIM) stock has risen 7.43% while the S&P 500 is lower by -0.29% as of 12:17 PM on Tuesday, May 31. ALIM has gained $0.43 from the previous closing price of $5.72 on volume of 14,166 shares. Over the past year the S&P 500 is lower by -1.33% while ALIM is lower by -39.29%. ALIM lost -$1.02 per share the over the last 12 months. Click Here to get the full Stock Report for Alimera Sciences Inc stock.